Risk of myocardial infarction with increasing quartiles of plasminogen
| . | Q1 . | Q2 . | Q3 . | Q4 . |
|---|---|---|---|---|
| Cutoff, % | 86 | 94 | 104 | |
| No. of patients | 112 | 125 | 144 | 174 |
| No. of control subjects | 171 | 152 | 155 | 156 |
| Model 1: age, OR (95% CI) | 1 | 1.2 (0.9-1.7) | 1.4 (1.0-1.9) | 1.7 (1.2-2.3) |
| Model 2: model 1 + CRP and smoking, OR (95% CI) | 1 | 1.0 (0.7-1.5) | 1.1 (0.8-1.5) | 1.1 (0.7-1.5) |
| Model 3: model 2 + triglycerides, total cholesterol, and alcohol use, OR (95% CI) | 1 | 1.0 (0.7-1.4) | 1.0 (0.7-1.5) | 0.9 (0.6-1.3) |
| Model 4: model 3 + α2-antiplasmin, OR (95% CI) | 1 | 0.9 (0.6-1.3) | 0.9 (0.6-1.3) | 0.8 (0.5-1.2) |
| . | Q1 . | Q2 . | Q3 . | Q4 . |
|---|---|---|---|---|
| Cutoff, % | 86 | 94 | 104 | |
| No. of patients | 112 | 125 | 144 | 174 |
| No. of control subjects | 171 | 152 | 155 | 156 |
| Model 1: age, OR (95% CI) | 1 | 1.2 (0.9-1.7) | 1.4 (1.0-1.9) | 1.7 (1.2-2.3) |
| Model 2: model 1 + CRP and smoking, OR (95% CI) | 1 | 1.0 (0.7-1.5) | 1.1 (0.8-1.5) | 1.1 (0.7-1.5) |
| Model 3: model 2 + triglycerides, total cholesterol, and alcohol use, OR (95% CI) | 1 | 1.0 (0.7-1.4) | 1.0 (0.7-1.5) | 0.9 (0.6-1.3) |
| Model 4: model 3 + α2-antiplasmin, OR (95% CI) | 1 | 0.9 (0.6-1.3) | 0.9 (0.6-1.3) | 0.8 (0.5-1.2) |
Plasminogen levels were missing for 1 control subject.
Q indicates quartile; and CRP, C-reactive protein.